PTC Therapeutics, Inc. Comprehensive Income
PTC Therapeutics, Inc. (PTCT) reported Comprehensive Income of $81.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-30
- PTC Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $81.05M.
- PTC Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$4.84M, a 100.55% decline year-over-year.
- PTC Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$130.39M.
- PTC Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $14.47M.
- PTC Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $719.03M.
- PTC Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$387.90M.
- PTC Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$632.68M.
- PTC Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$529.94M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $81.05M 10-Q · filed 2026-07-30 | $76.20M 10-Q · filed 2026-07-30 | -$54.19M derived: sum of 3 quarters · filed 2026-07-30 | -$39.72M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$4.84M 10-Q · filed 2026-05-07 | -$135.24M derived: sum of 2 quarters · filed 2026-05-07 | -$120.77M derived: sum of 3 quarters · filed 2026-05-07 | -$164.31M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$130.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$115.92M derived: sum of 2 quarters · filed 2026-02-19 | -$159.47M derived: sum of 3 quarters · filed 2026-07-30 | $719.03M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | $14.47M 10-Q · filed 2025-11-04 | -$29.07M derived: sum of 2 quarters · filed 2026-07-30 | $849.42M 10-Q · filed 2025-11-04 | $762.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$43.54M 10-Q · filed 2026-07-30 | $834.96M 10-Q · filed 2026-07-30 | $747.53M derived: sum of 3 quarters · filed 2026-07-30 | $653.03M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $878.50M 10-Q · filed 2026-05-07 | $791.07M derived: sum of 2 quarters · filed 2026-05-07 | $696.57M derived: sum of 3 quarters · filed 2026-05-07 | $586.45M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$87.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$181.93M derived: sum of 2 quarters · filed 2026-02-19 | -$292.05M derived: sum of 3 quarters · filed 2026-02-19 | -$387.90M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | -$94.50M 10-Q · filed 2025-11-04 | -$204.62M derived: sum of 2 quarters · filed 2025-11-04 | -$300.47M 10-Q · filed 2025-11-04 | -$467.15M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | -$110.12M 10-Q · filed 2025-08-07 | -$205.97M 10-Q · filed 2025-08-07 | -$372.65M derived: sum of 3 quarters · filed 2026-02-19 | -$494.58M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | -$95.85M 10-Q · filed 2025-05-06 | -$262.54M derived: sum of 2 quarters · filed 2026-02-19 | -$384.47M derived: sum of 3 quarters · filed 2026-02-19 | -$583.19M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | -$166.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$288.62M derived: sum of 2 quarters · filed 2026-02-19 | -$487.34M derived: sum of 3 quarters · filed 2026-02-19 | -$632.68M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | -$121.93M 10-Q · filed 2024-11-07 | -$320.66M derived: sum of 2 quarters · filed 2024-11-07 | -$466.00M 10-Q · filed 2024-11-07 | -$668.30M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$198.73M 10-Q · filed 2024-08-08 | -$344.07M 10-Q · filed 2024-08-08 | -$546.37M derived: sum of 3 quarters · filed 2025-02-27 | -$629.73M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$145.34M 10-Q · filed 2024-04-25 | -$347.64M derived: sum of 2 quarters · filed 2025-02-27 | -$431.00M derived: sum of 3 quarters · filed 2025-02-27 | -$554.23M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | -$202.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$285.66M derived: sum of 2 quarters · filed 2025-02-27 | -$408.89M derived: sum of 3 quarters · filed 2025-02-27 | -$529.94M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | -$83.36M 10-Q · filed 2023-10-26 | -$206.59M derived: sum of 2 quarters · filed 2023-10-26 | -$327.64M 10-Q · filed 2023-10-26 | -$462.23M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | -$123.23M 10-Q · filed 2023-08-03 | -$244.28M 10-Q · filed 2023-08-03 | -$378.87M derived: sum of 3 quarters · filed 2024-02-29 | -$499.36M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | -$121.05M 10-Q · filed 2023-04-27 | -$255.64M derived: sum of 2 quarters · filed 2024-02-29 | -$376.14M derived: sum of 3 quarters · filed 2024-02-29 | -$501.85M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | -$134.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$255.08M derived: sum of 2 quarters · filed 2024-02-29 | -$380.80M derived: sum of 3 quarters · filed 2024-02-29 | -$487.23M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | -$120.50M 10-Q · filed 2022-10-27 | -$246.21M derived: sum of 2 quarters · filed 2022-10-27 | -$352.64M 10-Q · filed 2022-10-27 | -$452.22M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-06-30 | -$125.71M 10-Q · filed 2022-08-04 | -$232.14M 10-Q · filed 2022-08-04 | -$331.73M derived: sum of 3 quarters · filed 2023-02-21 | -$427.13M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2021-03-31 | -$106.43M 10-Q · filed 2022-05-03 | -$206.01M derived: sum of 2 quarters · filed 2023-02-21 | -$301.42M derived: sum of 3 quarters · filed 2023-02-21 | -$490.87M derived: sum of 4 quarters · filed 2023-02-21 | ||||
| 2020-12-31 | -$99.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | -$194.99M derived: sum of 2 quarters · filed 2023-02-21 | -$384.44M derived: sum of 3 quarters · filed 2023-02-21 | -$488.53M 10-K · filed 2023-02-21 | ||||
| 2020-09-30 | -$95.40M 10-Q · filed 2021-10-28 | -$284.86M derived: sum of 2 quarters · filed 2021-10-28 | -$388.95M 10-Q · filed 2021-10-28 | -$477.83M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-06-30 | -$189.46M 10-Q · filed 2021-07-29 | -$293.55M 10-Q · filed 2021-07-29 | -$382.42M derived: sum of 3 quarters · filed 2022-02-22 | -$443.73M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2020-03-31 | -$104.09M 10-Q · filed 2021-05-04 | -$192.97M derived: sum of 2 quarters · filed 2022-02-22 | -$254.27M derived: sum of 3 quarters · filed 2022-02-22 | -$294.94M derived: sum of 4 quarters · filed 2022-02-22 | ||||
| 2019-12-31 | -$88.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$150.18M derived: sum of 2 quarters · filed 2022-02-22 | -$190.85M derived: sum of 3 quarters · filed 2022-02-22 | -$263.62M 10-K · filed 2022-02-22 | ||||
| 2019-09-30 | -$61.30M 10-Q · filed 2020-10-29 | -$101.97M derived: sum of 2 quarters · filed 2020-10-29 | -$174.75M 10-Q · filed 2020-10-29 | -$223.24M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$40.67M 10-Q · filed 2020-08-05 | -$113.44M 10-Q · filed 2020-08-05 | -$161.94M derived: sum of 3 quarters · filed 2021-02-25 | -$213.13M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$72.77M 10-Q · filed 2020-04-30 | -$121.27M derived: sum of 2 quarters · filed 2021-02-25 | -$172.46M derived: sum of 3 quarters · filed 2021-02-25 | -$185.08M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$48.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$99.69M derived: sum of 2 quarters · filed 2021-02-25 | -$112.31M derived: sum of 3 quarters · filed 2021-02-25 | -$130.59M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$51.20M 10-Q · filed 2019-10-30 | -$63.81M derived: sum of 2 quarters · filed 2019-10-30 | -$82.09M 10-Q · filed 2019-10-30 | -$79.87M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | -$12.62M 10-Q · filed 2019-08-06 | -$30.90M 10-Q · filed 2019-08-06 | -$28.67M derived: sum of 3 quarters · filed 2020-03-02 | -$61.40M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$18.28M 10-Q · filed 2019-05-02 | -$16.05M derived: sum of 2 quarters · filed 2020-03-02 | -$48.78M derived: sum of 3 quarters · filed 2020-03-02 | -$63.38M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$30.50M derived: sum of 2 quarters · filed 2020-03-02 | -$45.10M derived: sum of 3 quarters · filed 2020-03-02 | -$73.55M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | -$32.72M 10-Q · filed 2018-11-05 | -$47.32M derived: sum of 2 quarters · filed 2018-11-05 | -$75.77M 10-Q · filed 2018-11-05 | -$104.81M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | -$14.60M 10-Q · filed 2018-08-07 | -$43.05M 10-Q · filed 2018-08-07 | -$72.08M derived: sum of 3 quarters · filed 2019-03-01 | -$107.38M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | -$28.45M 10-Q · filed 2018-05-09 | -$57.48M derived: sum of 2 quarters · filed 2019-03-01 | -$92.78M derived: sum of 3 quarters · filed 2019-03-01 | -$131.89M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | -$29.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$64.33M derived: sum of 2 quarters · filed 2019-03-01 | -$103.45M derived: sum of 3 quarters · filed 2019-03-01 | -$142.40M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | -$35.30M 10-Q · filed 2017-11-02 | -$74.41M derived: sum of 2 quarters · filed 2017-11-02 | -$113.36M 10-Q · filed 2017-11-02 | -$164.38M derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2016-06-30 | -$39.11M 10-Q · filed 2017-08-09 | -$78.06M 10-Q · filed 2017-08-09 | -$129.08M derived: sum of 3 quarters · filed 2018-03-06 | -$172.94M derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2016-03-31 | -$38.95M 10-Q · filed 2017-05-08 | -$89.97M derived: sum of 2 quarters · filed 2018-03-06 | -$133.82M derived: sum of 3 quarters · filed 2018-03-06 | -$171.94M derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2015-12-31 | -$51.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | -$94.88M derived: sum of 2 quarters · filed 2018-03-06 | -$133.00M derived: sum of 3 quarters · filed 2018-03-06 | -$170.91M 10-K · filed 2018-03-06 | ||||
| 2015-09-30 | -$43.85M 10-Q · filed 2016-11-03 | -$81.97M derived: sum of 2 quarters · filed 2016-11-03 | -$119.89M 10-Q · filed 2016-11-03 | -$147.83M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | -$38.12M 10-Q · filed 2016-08-04 | -$76.03M 10-Q · filed 2016-08-04 | -$103.97M derived: sum of 3 quarters · filed 2017-03-16 | -$131.41M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | -$37.91M 10-Q · filed 2016-05-05 | -$65.85M derived: sum of 2 quarters · filed 2017-03-16 | -$93.29M derived: sum of 3 quarters · filed 2017-03-16 | -$118.39M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2014-12-31 | -$27.94M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$55.38M derived: sum of 2 quarters · filed 2017-03-16 | -$80.47M derived: sum of 3 quarters · filed 2017-03-16 | -$94.56M 10-K · filed 2017-03-16 | ||||
| 2014-09-30 | -$27.44M 10-Q · filed 2015-11-09 | -$52.53M derived: sum of 2 quarters · filed 2015-11-09 | -$66.62M 10-Q · filed 2015-11-09 | -$84.40M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | -$25.09M 10-Q · filed 2015-07-31 | -$39.18M 10-Q · filed 2015-07-31 | -$56.96M derived: sum of 3 quarters · filed 2016-02-29 | -$61.41M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$14.09M 10-Q · filed 2015-05-05 | -$31.86M derived: sum of 2 quarters · filed 2016-02-29 | -$36.32M derived: sum of 3 quarters · filed 2016-02-29 | -$50.91M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | -$17.78M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$22.23M derived: sum of 2 quarters · filed 2016-02-29 | -$36.82M derived: sum of 3 quarters · filed 2016-02-29 | -$51.50M 10-K · filed 2016-02-29 | -$51.50M 10-K · filed 2014-03-06 | |||
| 2013-09-30 | -$4.46M 10-Q · filed 2014-11-06 | -$4.46M 10-Q · filed 2013-11-14 | -$19.04M derived: sum of 2 quarters · filed 2014-11-06 | -$33.73M 10-Q · filed 2014-11-06 | -$33.73M 10-Q · filed 2013-11-14 | -$40.00M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-06-30 | -$14.59M 10-Q · filed 2014-08-07 | -$14.59M 10-Q · filed 2013-08-13 | -$29.27M 10-Q · filed 2014-08-07 | -$29.27M 10-Q · filed 2013-08-13 | -$35.54M derived: sum of 3 quarters · filed 2015-03-02 | -$42.84M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-03-31 | -$14.68M 10-Q · filed 2014-05-06 | -$20.96M derived: sum of 2 quarters · filed 2015-03-02 | -$28.25M derived: sum of 3 quarters · filed 2015-03-02 | -$34.32M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | -$6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$13.57M derived: sum of 2 quarters · filed 2015-03-02 | -$19.64M derived: sum of 3 quarters · filed 2015-03-02 | -$26.23M 10-K · filed 2015-03-02 | -$26.24M 10-K · filed 2014-03-06 | |||
| 2012-09-30 | -$7.30M 10-Q · filed 2013-11-14 | -$13.37M derived: sum of 2 quarters · filed 2013-11-14 | -$19.96M 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | -$6.07M 10-Q · filed 2013-08-13 | -$12.67M 10-Q · filed 2013-08-13 | ||||||
| 2011-12-31 | $30.90M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |